Nasus Pharma Ltd
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2022 | — | $-2.8M | — |
| Dec 2023 | — | $-3.8M | $193.0K |
| Jun 2024 | — | $-4.7M | $900.0K |
| Dec 2024 | — | $-3.2M | $284.0K |
| Jun 2025 | — | $-4.3M | $203.0K |
| Dec 2025 | — | $2.8M | $1.2M |
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2022 | — | $-2.8M | — |
| Dec 2023 | — | $-3.8M | $193.0K |
| Jun 2024 | — | $-4.7M | $900.0K |
| Dec 2024 | — | $-3.2M | $284.0K |
| Jun 2025 | — | $-4.3M | $203.0K |
| Dec 2025 | — | $2.8M | $1.2M |